Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Reddy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Free radical pathology in schizophrenia: a reviewR D Reddy, J K Yao
The Journal of Nursing Administration|May 1, 1973
Improving participation in voluntary actionD H Smith, R D Reddy
Schizophrenia Research|March 9, 2000
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patientsJ K Yao, S Leonard, R D Reddy
Biological Psychiatry|June 5, 1999
Human plasma glutathione peroxidase and symptom severity in schizophreniaJ K Yao, R D Reddy, D P van Kammen
CNS Drugs|July 21, 2001
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implicationsJ K Yao, R D Reddy, D P van Kammen
Molecular Psychiatry|April 30, 2009
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophreniaJ K Yao, G G Dougherty, R D Reddy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Free radical pathology in schizophrenia: a reviewR D Reddy, J K Yao
The Journal of Nursing Administration|May 1, 1973
Improving participation in voluntary actionD H Smith, R D Reddy
Schizophrenia Research|March 9, 2000
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patientsJ K Yao, S Leonard, R D Reddy
Biological Psychiatry|June 5, 1999
Human plasma glutathione peroxidase and symptom severity in schizophreniaJ K Yao, R D Reddy, D P van Kammen
CNS Drugs|July 21, 2001
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implicationsJ K Yao, R D Reddy, D P van Kammen
Molecular Psychiatry|April 30, 2009
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophreniaJ K Yao, G G Dougherty, R D Reddy, et al.
Pageof 1